Skip to content

Study · Randomized controlled trial · n = 82 · 2014

3 results

The effect of intranasal oxytocin on perceiving and understanding emotion on the Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT).

Cardoso C, Ellenbogen MA, Linnen AM

Emotion (Washington, D.C.)4 Nov 2013Cited by 28 (Europe PMC)

PMID24188065 (opens in a new tab)DOI10.1037/a0034314 (opens in a new tab)PepBankPUB-24188065
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In healthy participants, intranasal oxytocin led to higher ratings of emotional intensity in facial stimuli than placebo.

    In plain wordsIn healthy adults, nasal oxytocin made faces look more emotional than placebo did.

    Peptide
    Oxytocin
    Outcome
    IncreaseRated emotional intensity of facial stimuli
    Study

    n = 82

    Comparator
    Placebo
    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    24 IU · intranasalAs given in this study (human).

    Source sentences

    Summary
    As expected, participants administered intranasal oxytocin rated emotion in facial stimuli as expressing greater emotional intensity than those given a placebo.
    1 context sentence
    Summary · context
    Eighty-two participants (42 women) self-administered a 24 IU dose of intranasal oxytocin or a placebo in a double-blind, randomized experiment and then completed the perceiving and understanding emotion components of the Mayer-Salovey-Caruso Emotional Intelligence Test.
  2. 02HumanRandomized controlled trialEfficacy outcome

    In healthy participants, intranasal oxytocin impaired accurate identification of emotion in faces, based on agreement with a normative sample, versus placebo.

    In plain wordsIn healthy adults, nasal oxytocin made emotion identification in faces less accurate than placebo did.

    Peptide
    Oxytocin
    Outcome
    DecreaseAccuracy of emotion identification in faces (MSCEIT)
    Study

    n = 82

    Comparator
    Placebo
    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    24 IU · intranasalAs given in this study (human).

    Source sentences

    Summary
    Consequently, accurate identification of emotion in faces, based on agreement with a normative sample, was impaired in the oxytocin group relative to placebo.
    1 context sentence
    Summary · context
    Eighty-two participants (42 women) self-administered a 24 IU dose of intranasal oxytocin or a placebo in a double-blind, randomized experiment and then completed the perceiving and understanding emotion components of the Mayer-Salovey-Caruso Emotional Intelligence Test.
  3. 03HumanRandomized controlled trialEfficacy outcome

    In healthy participants, intranasal oxytocin had no effect on emotion tests that used nonsocial stimuli.

    In plain wordsIn healthy adults, nasal oxytocin did not change results on tests that did not use faces or people.

    Peptide
    Oxytocin
    Outcome
    No significant changeEmotion tests with nonsocial stimuli
    Study

    n = 82

    Comparator
    Placebo
    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    24 IU · intranasalAs given in this study (human).

    Source sentences

    Summary
    No such effect was observed for tests using nonsocial stimuli.
    1 context sentence
    Summary · context
    Eighty-two participants (42 women) self-administered a 24 IU dose of intranasal oxytocin or a placebo in a double-blind, randomized experiment and then completed the perceiving and understanding emotion components of the Mayer-Salovey-Caruso Emotional Intelligence Test.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 01:30 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:49 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.